|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 14/705 | (2006.01) |
| (11) | Number of the document | 0918797 |
| (13) | Kind of document | T |
| (96) | European patent application number | 97937148.1 |
| Date of filing the European patent application | 1997-08-06 | |
| (97) | Date of publication of the European application | 1999-06-02 |
| (45) | Date of publication and mention of the grant of the patent | 2006-03-29 |
| (46) | Date of publication of the claims translation | 2006-08-25 |
| (86) | Number | PCT/US1997/013884 |
| Date | 1997-08-06 |
| (87) | Number | WO 1998/006248 |
| Date | 1998-02-19 |
| (30) | Number | Date | Country code |
| 700737 | 1996-08-15 | US |
| (72) |
PONATH, Paul, D., US
RINGLER, Douglas, J., US
JONES, S., Tarran, GB
NEWMAN, Walter, US
SALDANHA, José, GB
BENDIG, Mary, M., GB
|
| (73) |
MILLENNIUM PHARMACEUTICALS, INC.,
75 Sidney Street, Cambridge, Massachusetts 02139,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuotas imunoglobulinas reaguojantis su alfa4beta7 integrinu |
| HUMANIZED IMMUNOGLOBULIN REACTIVE WITH ALPHA4BETA7 INTEGRIN |
| Payment date | Validity (years) | Amount | |
| 2016-07-19 | 20 | 347.00 EUR |